만성질환 관리 솔루션 시장 예측(-2032년) : 제품 유형별, 질환 유형별, 제공 형태별, 케어 환경별, 용도별, 최종사용자별, 지역별 세계 분석

According to Stratistics MRC, the Global Chronic Disease Management Solutions Market is accounted for $13.68 billion in 2025 and is expected to reach $25.83 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Chronic Disease Management Solutions are integrated healthcare approaches designed to monitor, treat, and manage long-term medical conditions such as diabetes, cardiovascular diseases, respiratory disorders, and arthritis. These solutions combine digital health platforms, remote patient monitoring, clinical decision support, and personalized care plans to improve patient outcomes. By enabling continuous tracking, medication adherence, and proactive interventions, they reduce hospitalizations and healthcare costs. Rooted in traditional care principles yet driven by technology, these solutions support sustained patient engagement, preventive care, and long-term health stability.

Market Dynamics:

Driver:

Rising Prevalence of Chronic Diseases

The rising prevalence of chronic diseases is a primary driver of the market. Increasing incidences of diabetes, cancer, cardiovascular disorders, and respiratory diseases are placing sustained pressure on healthcare systems worldwide. Aging populations, sedentary lifestyles, and unhealthy dietary patterns further accelerate disease burden. As these conditions require long-term monitoring and continuous care, healthcare providers and payers are increasingly adopting integrated digital solutions to improve outcomes, reduce complications, and manage escalating treatment costs effectively.

Restraint:

High Implementation & Maintenance Costs

High implementation and maintenance costs restrain the growth of the Chronic Disease Management Solutions market. Deploying advanced digital platforms requires significant upfront investment in infrastructure, software integration, data analytics, and skilled personnel. Ongoing expenses related to system upgrades, cybersecurity, and technical support further increase operational costs. Smaller healthcare facilities and providers in developing regions often face budget constraints, limiting adoption. These financial barriers can slow market penetration.

Opportunity:

Digital Health & Telemedicine Growth

The rapid growth of digital health and telemedicine presents a significant opportunity for the market. Advancements in remote patient monitoring, mobile health applications, and AI-driven analytics enable continuous care beyond traditional clinical settings. Telemedicine improves access to healthcare services, particularly for rural and underserved populations. Increasing acceptance of virtual consultations and home-based care models allows providers to manage chronic conditions more efficiently, enhance patient engagement, and reduce hospital visits, creating strong momentum for market expansion.

Threat:

Data Privacy & Security Concerns

Data privacy and security concerns pose a major threat to the market. These platforms handle large volumes of sensitive patient health information, making them vulnerable to cyberattacks, data breaches, and unauthorized access. Stringent regulatory requirements regarding data protection increase compliance complexity for solution providers. Any lapse in data security can erode patient trust, lead to legal penalties, and disrupt operations, potentially hindering adoption and slowing the overall growth of digital chronic disease management systems.

Covid-19 Impact:

The Covid-19 pandemic had a notable impact on the market. Disruptions in routine care initially challenged chronic disease management, but the crisis accelerated adoption of digital health tools and remote monitoring solutions. Healthcare systems increasingly relied on telemedicine to ensure continuity of care for chronic patients. Post-pandemic, sustained emphasis on remote care and digital monitoring has strengthened long-term market growth, while highlighting the importance of resilient, technology-enabled healthcare delivery models.

The cancer segment is expected to be the largest during the forecast period

The cancer segment is expected to account for the largest market share during the forecast period, due to rising global cancer burden and the need for continuous, long-term care management. Cancer patients require ongoing monitoring, treatment adherence, symptom tracking, and post-therapy support, all of which are enabled by chronic disease management solutions. Digital platforms support personalized oncology care, improve coordination among specialists, and enhance patient outcomes, driving strong adoption across hospitals and specialty care centers worldwide.

The diabetes management segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diabetes management segment is predicted to witness the highest growth rate, due to rapidly increasing prevalence of diabetes globally. Continuous glucose monitoring, remote patient tracking, and data-driven care plans significantly improve disease control and patient compliance. Growing adoption of wearable devices, mobile health applications, and AI-enabled analytics supports real-time decision-making. Rising awareness of preventive care and self-management further accelerates demand, positioning diabetes management as the fastest-growing application segment.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to large patient population and rising prevalence of chronic diseases. Rapid urbanization, aging demographics, and lifestyle changes have increased demand for long-term disease management solutions. Government initiatives promoting digital healthcare, expanding healthcare infrastructure, and growing adoption of technology-enabled care models across countries such as China, India, and Japan further support the region's dominant market position.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong adoption of advanced digital health technologies and well-established healthcare infrastructure. High chronic disease prevalence, favorable reimbursement policies, and increasing use of telemedicine drive rapid market expansion. Continuous innovation in remote monitoring, AI-based analytics, and personalized care solutions, combined with strong patient awareness and provider readiness, positions North America as the fastest-growing regional market.

Key players in the market

Some of the key players in Chronic Disease Management Solutions Market include Health Catalyst, Allscripts Healthcare Solutions, Cedar Gate Technologies, IBM Watson Health, Cognizant, Optum, Pegasystems Inc., Medtronic, Koninklijke Philips N.V., Teladoc Health, Siemens Healthineers, ZeOmega, Cerner Corporation, WellSky, and Epic Systems Corporation.

Key Developments:

In November 2025, Siemens Healthineers introduced Syngo Carbon 2.0, an upgraded enterprise imaging platform. The launch integrates multimodal imaging data, AI-powered workflow automation, and cloud-based collaboration, designed to streamline radiology operations and improve diagnostic accuracy across global healthcare systems.

In October 2025, Siemens Healthineers expanded its collaboration with Varian and multiple oncology centers to accelerate precision therapy solutions. The joint venture integrates imaging, radiation therapy, and AI-driven planning tools, aiming to improve cancer treatment outcomes and strengthen Siemens' leadership in oncology care.

Products Covered:

• Software
• Devices
• Services
• Integrated Solutions

Disease Types Covered:

• Cardiovascular Diseases
• Asthma
• Diabetes
• Chronic Obstructive Pulmonary Disorders (COPD)
• Cancer
• Other Disease Types

Delivery Modes Covered:

• On-Premise
• Cloud-Based
• Hybrid Models

Care Settings Covered:

• Inpatient Care
• Home Based Care
• Outpatient Care
• Community Based Care

Applications Covered:

• Diabetes Management
• Cancer Care Management
• Cardiovascular Disease Management
• Respiratory Disease Management
• Other Applications

End Users Covered:

• Hospitals & Clinics
• Patients & Caregivers
• Home Healthcare Providers
• Employers & Corporate Wellness Programs
• Payers & Insurance Providers
• Pharmaceutical & Life Science Companies

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Chronic Disease Management Solutions Market, By Product

• 5.1 Introduction
• 5.2 Software
• 5.3 Devices
• 5.4 Services
• 5.5 Integrated Solutions

6 Global Chronic Disease Management Solutions Market, By Disease Type

• 6.1 Introduction
• 6.2 Cardiovascular Diseases
• 6.3 Asthma
• 6.4 Diabetes
• 6.5 Chronic Obstructive Pulmonary Disorders (COPD)
• 6.6 Cancer
• 6.7 Other Disease Types

7 Global Chronic Disease Management Solutions Market, By Delivery Mode

• 7.1 Introduction
• 7.2 On-Premise
• 7.3 Cloud-Based
• 7.4 Hybrid Models

8 Global Chronic Disease Management Solutions Market, By Care Setting

• 8.1 Introduction
• 8.2 Inpatient Care
• 8.3 Home Based Care
• 8.4 Outpatient Care
• 8.5 Community Based Care

9 Global Chronic Disease Management Solutions Market, By Application

• 9.1 Introduction
• 9.2 Diabetes Management
• 9.3 Cancer Care Management
• 9.4 Cardiovascular Disease Management
• 9.5 Respiratory Disease Management
• 9.6 Other Applications

10 Global Chronic Disease Management Solutions Market, By End User

• 10.1 Introduction
• 10.2 Hospitals & Clinics
• 10.3 Patients & Caregivers
• 10.4 Home Healthcare Providers
• 10.5 Employers & Corporate Wellness Programs
• 10.6 Payers & Insurance Providers
• 10.7 Pharmaceutical & Life Science Companies

11 Global Chronic Disease Management Solutions Market, By Geography

• 11.1 Introduction
• 11.2 North America
  • 11.2.1 US
  • 11.2.2 Canada
  • 11.2.3 Mexico
• 11.3 Europe
  • 11.3.1 Germany
  • 11.3.2 UK
  • 11.3.3 Italy
  • 11.3.4 France
  • 11.3.5 Spain
  • 11.3.6 Rest of Europe
• 11.4 Asia Pacific
  • 11.4.1 Japan
  • 11.4.2 China
  • 11.4.3 India
  • 11.4.4 Australia
  • 11.4.5 New Zealand
  • 11.4.6 South Korea
  • 11.4.7 Rest of Asia Pacific
• 11.5 South America
  • 11.5.1 Argentina
  • 11.5.2 Brazil
  • 11.5.3 Chile
  • 11.5.4 Rest of South America
• 11.6 Middle East & Africa
  • 11.6.1 Saudi Arabia
  • 11.6.2 UAE
  • 11.6.3 Qatar
  • 11.6.4 South Africa
  • 11.6.5 Rest of Middle East & Africa

12 Key Developments

• 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 12.2 Acquisitions & Mergers
• 12.3 New Product Launch
• 12.4 Expansions
• 12.5 Other Key Strategies

13 Company Profiling

• 13.1 Health Catalyst
• 13.2 Allscripts Healthcare Solutions
• 13.3 Cedar Gate Technologies
• 13.4 IBM Watson Health
• 13.5 Cognizant
• 13.6 Optum
• 13.7 Pegasystems Inc.
• 13.8 Medtronic
• 13.9 Koninklijke Philips N.V.
• 13.10 Teladoc Health
• 13.11 Siemens Healthineers
• 13.12 ZeOmega
• 13.13 Cerner Corporation
• 13.14 WellSky
• 13.15 Epic Systems Corporation